Novartis India Limited (NOVARTIND)
ISIN: - Industry: Drug Manufacturers—Specialty & Generic Sector: Healthcare Website
663.9
-8.55(-1.27%)

Novartis India Limited operates as a healthcare company in India. It offers pharmaceutical products in the areas of bone and pain, calcium portfolio, gynecology, and neurosciences, as well as generics products in the areas of gynecology, anti-TB, and anti-infectives. The company provides central nervous system products under the Tegrital and Exelon brands; pain and inflammation products under the Voveran brand; and transplantation/immunology products under the Simulect, Certican, Myfortic, and Sandimmun Neoral brands. The company was incorporated in 1947 and is headquartered in Mumbai, India. Novartis India Limited is a subsidiary of Novartis AG.

Pricing Updates

TODAY'S HIGH

680.7

TODAY'S LOW

656.05

52 WEEK HIGH

1098

52 WEEK LOW

565.3

Major Holders

% of Shares Held by
All Insider

72.72%

% of Shares Held by
Institutions

0.08%

% of Float Held by
Institutions

0.31%

Number of Institutions
Holding Shares

2

Company Overview

MARKET CAP

1639.22 Cr.

ETERPRISE VALUE

1168.05 Cr.

NO. OF SHARES

2.46 Cr.

BOOK VALUE

280.145

DIV. YIELD

10%

DEBT

24.01 Cr.

GROSS PROFIT

221.71 Cr.

CASH

516.28 Cr.

REVENUE

399.87 Cr.

REVENUE/SHARE

161.951

OHLC Chart 1y 2y 5y 10y

Price Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Volumes Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Cashflows

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Investments72 Cr.69.79 Cr.18.15 Cr.213.69 Cr.
Change To Liabilities14.83 Cr.-17.38 Cr.-22.09 Cr.-10.87 Cr.
Total cashflows from Investing Activities87.04 Cr.95.16 Cr.55.91 Cr.274.23 Cr.
Net Borrowings-10.90 Cr.-12.03 Cr.-5.25 Cr.-5.25 Cr.
Total Cash from Financing Activities-35.63 Cr.-36.80 Cr.-41.41 Cr.-29.82 Cr.
Other Liabilities65.21 Cr.-61.51 Cr.10.27 Cr.-144.52 Cr.
Total Assets0000
Net Income-3.72 Cr.20.90 Cr.10.08 Cr.51.77 Cr.
Change in Cash90.08 Cr.-10.85 Cr.-8.64 Cr.50.13 Cr.
Effect of Exchange Rate0000
Total Cash from Operating Activities38.67 Cr.-69.21 Cr.-23.14 Cr.-194.28 Cr.
Depreciation9.65 Cr.12.16 Cr.13.14 Cr.3.18 Cr.
Other Cashflows from Investing Activities15.54 Cr.20.78 Cr.38.70 Cr.44.39 Cr.
Dividends Paid-24.69 Cr.-24.69 Cr.-24.69 Cr.-24.74 Cr.
Change to Inventory-9.12 Cr.10.73 Cr.1.83 Cr.-3.95 Cr.
Change to Account Receivables-4.20 Cr.-92 Lakhs8.14 Cr.-2.42 Cr.
Other Cashflows from Financing Activities-4 Lakhs-8 Lakhs-11.47 Cr.-5.08 Cr.
Change to Net Income-33.98 Cr.-33.19 Cr.-44.51 Cr.-87.47 Cr.
Capital Expenditures-50 Lakhs-9 Lakhs-1 Cr.-14.06 Cr.

Financials

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Research DevelopmentNoneNoneNoneNone
Effect of Accounting ChargesNoneNoneNoneNone
Income Before Tax-3.82 Cr.40.04 Cr.28.64 Cr.85.77 Cr.
Minority InterestNoneNoneNoneNone
Net Income23.94 Cr.18.81 Cr.84 Lakhs12.65 Cr.
Selling General Administrative109.71 Cr.118.71 Cr.128.23 Cr.148 Cr.
Gross Profit221.71 Cr.234.61 Cr.255.61 Cr.290.96 Cr.
Ebit23.94 Cr.18.81 Cr.84 Lakhs12.65 Cr.
Operating Income23.94 Cr.18.81 Cr.84 Lakhs12.65 Cr.
Other Operating Expenses78.41 Cr.84.93 Cr.113.40 Cr.127.13 Cr.
Interest Expense-4.83 Cr.-7.68 Cr.-6.39 Cr.-1.59 Cr.
Extraordinary ItemsNoneNoneNoneNone
Non RecurringNoneNoneNoneNone
Other ItemsNoneNoneNoneNone
Income Tax Expense-10 Lakhs19.14 Cr.18.56 Cr.34 Cr.
Total Revenue399.87 Cr.381.35 Cr.438.25 Cr.490.68 Cr.
Total Operating Expenses375.93 Cr.362.54 Cr.437.41 Cr.478.03 Cr.
Cost of Revenue178.16 Cr.146.74 Cr.182.64 Cr.199.72 Cr.
Total Other Income Expense Net-27.76 Cr.21.23 Cr.27.80 Cr.73.12 Cr.
Discontinued OperationsNoneNoneNoneNone
Net Income from Continuous Ops.-3.72 Cr.20.90 Cr.10.08 Cr.51.77 Cr.
Net Income Applicable to Common Shares-3.72 Cr.20.90 Cr.10.08 Cr.51.77 Cr.

Balance Sheet

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Intangible Assets0000
Capital Surplus0000
Total Liabilities265.87 Cr.291.10 Cr.356.91 Cr.223.25 Cr.
Stock Holder Equity691.70 Cr.711.19 Cr.720.73 Cr.759.19 Cr.
Minority Interest0000
Other Liabilities104.03 Cr.70.66 Cr.132.27 Cr.83.39 Cr.
Total Assets957.57 Cr.1002.29 Cr.1077.64 Cr.982.44 Cr.
Common Stock12.34 Cr.12.34 Cr.12.34 Cr.12.34 Cr.
Retained Earnings677.94 Cr.698.16 Cr.708.04 Cr.747.46 Cr.
Other Liabilities31.18 Cr.82.37 Cr.67.66 Cr.38.24 Cr.
Good Will0000
Treasury Stock1.42 Cr.69 Lakhs35 Lakhs-61 Lakhs
Other Assets225.28 Cr.214.42 Cr.188.42 Cr.160.40 Cr.
Cash158.35 Cr.68.27 Cr.79.12 Cr.87.76 Cr.
Current Liabilities216.42 Cr.158.95 Cr.232.79 Cr.185.01 Cr.
Long Term Asset Charges27.18 Cr.30.27 Cr.24.74 Cr.21.44 Cr.
Short Long Term Debt0000
Other Stockholder Equity1.42 Cr.69 Lakhs35 Lakhs-61 Lakhs
Property Plant Equipment23.65 Cr.63.91 Cr.76.28 Cr.14.98 Cr.
Total Cur. Assets707.82 Cr.723.13 Cr.812.11 Cr.806.47 Cr.
Long Term Investments82 Lakhs83 Lakhs83 Lakhs59 Lakhs
Net Tangible Assets691.70 Cr.711.19 Cr.720.73 Cr.759.19 Cr.
Short Term Investments357.94 Cr.429.14 Cr.501.27 Cr.522.74 Cr.
Net Receivables56.66 Cr.84.40 Cr.88.65 Cr.77.89 Cr.
Long Term Debt0000
Inventory57.07 Cr.47.95 Cr.58.68 Cr.60.51 Cr.
Accounts Payable72.20 Cr.55.20 Cr.72.60 Cr.91.40 Cr.

New Offers


Upstox offer
Upstox

Open a demat account through us and get the account opening charges waived off

open paperless account